HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262

NCT05740813 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

310

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: ABBV-CLS-7262 Dose 1
DRUG: ABBV-CLS-7262 Dose 2
DRUG: Matching Placebo

Sponsor

Merit E. Cudkowicz, MD

Collaborators

[object Object]